Live news related to GENFIT stock (FR0004163111): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
GENFIT reaches a new milestone this Thursday, February 19, hitting a high since the April 2020 drop during the Covid crisis. The Lille-based biotech's…
Oddo BHF établit une recommandation surperformer sur Genfit et fixe un objectif de cours à 15 €.
GENFIT will receive a milestone payment of $20 million following the surpassing of $200 million in net sales for Iqirvo® in its first full year of com…
On January 7, the biopharmaceutical group Genfit released its financial calendar for the year 2026, according to a statement distributed to investors.
According to a press release from GENFIT, GNS561 has demonstrated promising antitumor activity when used in combination therapy.
The biopharmaceutical company GENFIT (Euronext and Nasdaq: GNFT) announces that the voluntary withdrawal of its American Depositary Shares (ADS) from …
Genfit announces a research collaboration with EVerZom to develop exosome-based technologies in the field of regeneration, particularly for ACLF.
Genfit has announced its intention to voluntarily withdraw its American Depositary Shares from the Nasdaq Global Select Market.
Genfit has announced progress in its pipeline regarding ACLF at The Liver Meeting 2025 hosted by AASLD.
